IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 317 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 1.23 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $2,000 | 0.0% | 35 | 0.0% | 0.00% | – |
Q3 2019 | $2,000 | 0.0% | 35 | 0.0% | 0.00% | – |
Q2 2019 | $2,000 | 0.0% | 35 | +25.0% | 0.00% | – |
Q1 2019 | $2,000 | +100.0% | 28 | 0.0% | 0.00% | – |
Q4 2018 | $1,000 | 0.0% | 28 | 0.0% | 0.00% | – |
Q3 2018 | $1,000 | -96.6% | 28 | -96.0% | 0.00% | -100.0% |
Q2 2018 | $29,000 | -3.3% | 708 | 0.0% | 0.00% | -33.3% |
Q1 2018 | $30,000 | -18.9% | 708 | 0.0% | 0.00% | -25.0% |
Q4 2017 | $37,000 | -22.9% | 708 | -23.5% | 0.00% | -20.0% |
Q3 2017 | $48,000 | +9.1% | 926 | 0.0% | 0.01% | 0.0% |
Q2 2017 | $44,000 | -13.7% | 926 | -14.9% | 0.01% | -16.7% |
Q1 2017 | $51,000 | +59.4% | 1,088 | -8.3% | 0.01% | +50.0% |
Q4 2016 | $32,000 | 0.0% | 1,186 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $32,000 | -3.0% | 1,186 | -18.0% | 0.00% | 0.0% |
Q2 2016 | $33,000 | -26.7% | 1,447 | +8.6% | 0.00% | -20.0% |
Q1 2016 | $45,000 | -6.2% | 1,332 | +68.4% | 0.01% | -44.4% |
Q4 2015 | $48,000 | – | 791 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BB BIOTECH AG | 6,529,838 | $404,393,000 | 11.39% |
DOWLING & YAHNKE LLC | 676,379 | $41,888,000 | 5.27% |
Opus Point Partners Management, LLC | 102,459 | $6,345,000 | 4.19% |
WILLIAM HARRIS INVESTORS INC | 230,443 | $14,271,000 | 3.43% |
PINNACLE ASSOCIATES LTD | 1,690,263 | $104,678,000 | 2.20% |
MESSNER & SMITH THEME VALUE INVESTMENT MANAGEMENT LTD /CA/ | 21,298 | $1,319,000 | 2.11% |
Sonora Investment Management, LLC | 126,763 | $7,850,000 | 2.04% |
Virtus ETF Advisers LLC | 10,447 | $647,000 | 1.78% |
Apex Capital Management | 1,020,096 | $63,175,000 | 1.41% |
PERKINS CAPITAL MANAGEMENT INC | 19,900 | $1,232,000 | 1.32% |